Due to the potential importance of such ESR1 alterations in endometrial cancer, we analyzed an tumor test subset of 29 primary endometrial cancers for somatic gene copy-number alterations (SCNA) and explored The Cancer Genome Atlas (TCGA)33 for concerning SCNA and mRNA expression data of endometrial carcinoma. This evidence concerns the gene ESR1 and neoplasm.